PembrolizumabImmunoglobulin A pemphigus : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2020卷 / 1期

关键词：

D O I：

10.1007/s40278-024-64745-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：380 / 380

相关论文

共 50 条

[1] PembrolizumabImmunoglobulin-A nephropathy: case report
Reactions Weekly, 2024, 2036 (1) : 389 - 389
[2] AcetazolamideFirst report of pemphigus: case report
Reactions Weekly, 2009, 1272 (1) : 5 - 5
[3] CyclophosphamideFirst report of pemphigus: case report
Reactions Weekly, 2004, 1013 (1) : 8 - 8
[4] IbrutinibParaneoplastic pemphigus: case report
Reactions Weekly, 2018, 1685 (1) : 101 - 101
[5] VedolizumabBullous Pemphigus: case report
Reactions Weekly, 2018, 1693 (1) : 496 - 496
[6] VedolizumabBullous Pemphigus: case report
Reactions Weekly, 2018, 1700 (1) : 251 - 251
[7] RituximabReactivation of pemphigus: case report
Reactions Weekly, 2020, 1795 (1) : 240 - 240
[8] Pemphigus vulgaris: a case report
Thanmai, Janumpally Varshitha
Ramlal, Gantala
Tejaswi, Katne
Mounica, Inukonda Lakshmi
PAN AFRICAN MEDICAL JOURNAL, 2022, 42
[9] VedolizumabBullous Pemphigus: case report
Reactions Weekly, 2018, 1699 (1) : 296 - 296
[10] Syphilitic pemphigus: a case report
Mejia, Elvis Pineres
Mendieta, Carlos Ospina
PEDIATRIA-ASUNCION, 2021, 48 (01): : 78 - 83

← 1 2 3 4 5 →